pioglitazone has been researched along with Bronchopulmonary Dysplasia in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keith, RL | 1 |
| Blatchford, PJ | 1 |
| Merrick, DT | 1 |
| Bunn, PA | 1 |
| Bagwell, B | 1 |
| Dwyer-Nield, LD | 1 |
| Jackson, MK | 1 |
| Geraci, MW | 1 |
| Miller, YE | 1 |
1 trial available for pioglitazone and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers.
Topics: Aged; Biopsy; Bronchopulmonary Dysplasia; Bronchoscopy; Carcinoma in Situ; Chemoprevention; Double-B | 2019 |